AGM/EGMApr 30, 2026, 04:59 PM
ANVS Sets 2026 Annual Meeting for June 17; Key Proposals
AI Summary
Annovis Bio, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 17, 2026, with April 28, 2026, as the record date. Shareholders will vote on the election of five director nominees, the ratification of Ernst & Young LLP as the independent auditor, and an amendment to the 2019 Equity Incentive Plan. Additionally, there will be advisory votes on executive compensation and the frequency of such votes, with the Board recommending every two years. The Board unanimously recommends voting "FOR" all proposals.
Key Highlights
- 2026 Annual Meeting of Stockholders to be held virtually on June 17, 2026.
- Record date for voting is April 28, 2026.
- Shareholders to elect five director nominees.
- Shareholders to ratify Ernst & Young LLP as independent auditor for FY2026.
- Proposal to approve an amendment to the 2019 Equity Incentive Plan.
- Advisory vote on executive compensation and its frequency (Board recommends every two years).
- 34,646,868 shares of common stock outstanding as of record date.
- Directors and officers beneficially own approximately 14.3% of outstanding common stock.
Price Impact
More from ANVS